Mei Ri Jing Ji Xin Wen·2025-06-16 09:34Group 1 - The event organized by Dongfang Securities aimed to enhance investor protection and transparency of listed companies, aligning with the new "National Nine Articles" policy [1] - The event featured a visit to the Guilin production base of Lain Bio, showcasing its advanced technologies and digital management processes in the plant extraction industry [1] - Lain Bio's production line for enzyme-synthesized RebM2 is the first of its kind globally, offering significant advantages over traditional methods, including lower energy consumption and higher raw material utilization [1] Group 2 - The company expects to produce over 1,000 tons of enzyme-synthesized products annually, with an estimated annual output value exceeding 1 billion yuan [1] - During the investor communication session, Lain Bio's secretary emphasized the importance of ongoing dialogue between the company and its investors [3] - Investors expressed increased confidence in Lain Bio's development after witnessing its operations firsthand, highlighting the event's role in enhancing understanding of the plant extraction industry's technological and market potential [3]